To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to establish maximum permissible levels for contaminants in infant formulas, and for other purposes.
Summary
HR9788, introduced by Rep. Mast, proposes to set maximum contaminant levels in infant formula. It is in early legislative stages, referred to committee with no funding authorized. No direct market impact is expected at this stage.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR9788 is in early legislative stages with no funding authorized.
- 2.No direct market impact until specific contaminant levels are set and enforced.
- 3.Infant formula manufacturers may face future compliance costs, but no immediate effect.
Market Implications
No immediate market implications. The bill's early stage and lack of funding mean no direct impact on publicly traded companies. Investors should watch for committee action or amendments that could specify enforcement mechanisms or compliance costs.
Full Analysis
On July 20, 2026, Rep. Brian Mast (R-FL) introduced HR9788, a bill to amend the Federal Food, Drug, and Cosmetic Act to direct the HHS Secretary to establish maximum permissible levels for contaminants in infant formulas. The bill has been referred to the House Committee on Energy and Commerce and has one cosponsor, Rep. Buddy Carter (R-GA). As an early-stage authorization bill, it sets policy direction but does not appropriate any funding. The legislative path requires committee hearings, markup, floor votes in both chambers, and presidential action before any regulatory changes take effect. No specific companies or tickers are directly impacted at this stage, as the bill does not name any firm or allocate funds. The infant formula market includes major players like Abbott Laboratories ($ABT) and Reckitt Benckiser ($RBGLY), but the bill's impact on their operations is speculative until specific contaminant levels are proposed and enforced. The timeline for this bill is uncertain, with no scheduled hearings or markups.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $773M Department of Veterans Affairs Contract
TRIWEST HEALTHCARE ALLIANCE CORP: $874M Department of Veterans Affairs Contract
TRIWEST HEALTHCARE ALLIANCE CORP: $903M Department of Veterans Affairs Contract
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $641M Department of Veterans Affairs Contract
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $598M Department of Veterans Affairs Contract
Executive Order: Promoting Efficiency, Accountability, and Performance in Federal Contracting
Executive Order: Accelerating Medical Treatments for Serious Mental Illness
Proclamation: Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →